These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 516068)

  • 1. Allylamine cardiotoxicity: I. Sequence of pathologic events.
    Boor PJ; Moslen MT; Reynolds ES
    Toxicol Appl Pharmacol; 1979 Sep; 50(3):581-92. PubMed ID: 516068
    [No Abstract]   [Full Text] [Related]  

  • 2. Allylamine cardiotoxicity: metabolism and mechanism.
    Boor PJ
    Adv Exp Med Biol; 1983; 161():533-41. PubMed ID: 6346821
    [No Abstract]   [Full Text] [Related]  

  • 3. Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo derangements of monoamine oxidase.
    Boor PJ; Nelson TJ
    Toxicology; 1980; 18(2):87-102. PubMed ID: 7256782
    [No Abstract]   [Full Text] [Related]  

  • 4. Allylamine cardiotoxicity: II. Histopathology and histochemistry.
    Boor PJ; Nelson TJ; Chieco P
    Am J Pathol; 1980 Sep; 100(3):739-64. PubMed ID: 6448005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased DNA synthesis in the heart during acute allylamine cardiotoxicity.
    Boor PJ; Kretschmer N
    Res Commun Chem Pathol Pharmacol; 1990 Apr; 68(1):3-11. PubMed ID: 2345804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allylamine and beta-aminopropionitrile-induced vascular injury: an in vivo and in vitro study.
    Kumar D; Hysmith RM; Boor PJ
    Toxicol Appl Pharmacol; 1990 Apr; 103(2):288-302. PubMed ID: 2330590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural alterations in allylamine- induced cardiomyopathy: early lesions.
    Boor PJ; Ferrans VJ
    Lab Invest; 1982 Jul; 47(1):76-86. PubMed ID: 7087400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative angiotoxic responses of avian and rodent species in vivo: implications in atherogenesis.
    Ramos K
    J Toxicol Environ Health; 1990; 29(4):357-76. PubMed ID: 2325152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hygienic establishment of the maximum permissible concentration of allylamine in the water of reservoirs].
    Ilichkina AG; Toropkov VV; Verenikina BI
    Gig Sanit; 1983 Jan; (1):80-2. PubMed ID: 6826079
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiotoxicity study of amsacrine in rats.
    Kim SN; Watkins JR; Jayasekara U; Anderson JA; Fitzgerald JE; de la Iglesia FA
    Toxicol Appl Pharmacol; 1985 Mar; 77(3):369-73. PubMed ID: 3838387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural alterations in allylamine cardiovascular toxicity. Late myocardial and vascular lesions.
    Boor PJ; Ferrans VJ
    Am J Pathol; 1985 Oct; 121(1):39-54. PubMed ID: 4050976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allylamine and acrolein toxicity in perfused rat hearts.
    Sklar JL; Anderson PG; Boor PJ
    Toxicol Appl Pharmacol; 1991 Mar; 107(3):535-44. PubMed ID: 2000639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allylamine cardiovascular toxicity.
    Boor PJ; Hysmith RM
    Toxicology; 1987 May; 44(2):129-45. PubMed ID: 3551196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of essential phospholipids (EPL) on experimental cobalt-induced cardiomyopathy.
    Wójcicki J; Rózewicka L; Kadyków M
    Arzneimittelforschung; 1973 Aug; 23(8):1070-4. PubMed ID: 4358339
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute hyperkalemic cardiomyopathy in the dog.
    Ojiambo HP; Petrie R; Dusek J; Klassen GA
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():579-87. PubMed ID: 4681484
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental cobalt cardiomyopathy.
    Mohiuddin SM; Taskar PK; Rheault M; Roy PE; Chenard J; Morin Y
    Am Heart J; 1970 Oct; 80(4):532-43. PubMed ID: 5471215
    [No Abstract]   [Full Text] [Related]  

  • 17. Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy.
    Campos EC; O'Connell JL; Malvestio LM; Romano MM; Ramos SG; Celes MR; Prado CM; Simões MV; Rossi MA
    Eur J Pharmacol; 2011 Nov; 670(2-3):541-53. PubMed ID: 21946105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues.
    Nelson TJ; Boor PJ
    Biochem Pharmacol; 1982 Feb; 31(4):509-14. PubMed ID: 7066019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamine protects against doxorubicin-induced cardiotoxicity.
    Cao Y; Kennedy R; Klimberg VS
    J Surg Res; 1999 Jul; 85(1):178-82. PubMed ID: 10383856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of lupeol and its ester on cyclophosphamide-induced hyperlipidaemic cardiomyopathy in rats.
    Sudharsan PT; Mythili Y; Sudhahar V; Varalakshmi P
    J Pharm Pharmacol; 2005 Nov; 57(11):1437-44. PubMed ID: 16259776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.